These genes likely play critical roles in cancer progression because cBioPortal analysis revealed amplification and /or mutations of TMEM47, LYPD1 and SLITRK2 in a variety of cancers including breast cancer [30]. This evidence concerns the gene SLITRK2 and breast carcinoma.